Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer.

These findings suggest that adjuvant therapy may have limited benefit for patients treated with induction chemotherapy followed by local control with IRE for unresectable pancreatic cancer. Further study of the duration and timing of systemic therapy is warranted to maximize benefit and limit toxicity.